Abstract
In December 2019, a respiratory disease caused by a coronavirus called SARS-CoV-2 (COVID-19) began in Wuhan, China, and quickly became a pandemic. In such situations, pregnant women are suspected of being among the vulnerable groups. The aim of this study was to report clinical symptoms, laboratory findings, and obstetrical complications, maternal, fetal, and neonatal complications of COVID-19 infection in pregnant women. We searched the Cochrane library, MEDLINE/PubMed, and Web of Sciences from their inception to April 5, 2020. Any study involving pregnant women with COVID-19 which evaluated the effect of the disease on pregnancy outcomes and fetal and neonatal complications was included in the study. The outcomes were the symptoms and laboratory findings, obstetrical complications, mode of delivery, and maternal, fetal, and neonatal complications. The search resulted in 69 titles and abstracts, which were narrowed down to 12 studies involving 68 women. The three most common symptoms of patients were fever, cough, and fatigue. The most common laboratory findings were an increase in C-reactive protein (CRP) and lymphopenia. The most common obstetrical complication was preterm labor (33.3%). No maternal deaths were reported. The Cesarean section rate was 83.3% and the vertical transition rate was 2.23%. The findings showed that the clinical symptoms and laboratory measures of pregnant women affected by COVID-19 did not differ from the general population. In general, the prognosis of mothers who suffered from COVID-19 and their newborns was satisfactory. However, there is a need for further rigorous studies to confirm these findings as the pandemic progresses.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Guarner J (2020) Three emerging coronaviruses in two decades: the story of SARS, MERS, and now COVID-19. Am J Clin Pathol 153(4):420–421
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C et al (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8(4):420–422
Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC et al (2004) Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 191(1):292–297
Dashraath P, Jeslyn WJL, Karen LMX, Min LL, Sarah L, Biswas A et al (2020) Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy. Am J Obstet Gynecol. pii: S0002–9378(20)30343–4. https://doi.org/10.1016/j.ajog.2020.03.021. [Epub ahead of print]
Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W et al (2020) Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 395(10226):809–815
Chen S, Liao E, Shao Y (2020) Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia. J Med Virol. https://doi.org/10.1002/jmv.25789. [Epub ahead of print]
Dong L, Tian J, He S, Zhu C, Wang J, Liu C et al (2020) Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA. https://doi.org/10.1001/jama.2020.4621. [Epub ahead of print]
Li Y, Zhao R, Zheng S, Chen X, Wang J, Sheng X et al (2020) Lack of vertical transmission of severe acute respiratory syndrome coronavirus 2, China. Emerg Infect Dis 26(6). https://doi.org/10.3201/eid2606.200287. [Epub ahead of print]
Liu Y, Chen H, Tang K, Guo Y (2020) Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect. pii: S0163–4453(20)30109–2. https://doi.org/10.1016/j.jinf.2020.02.028. [Epub ahead of print]
Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G et al (2020) Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Translat Pediatr 9(1):51–60
Fan C, Lei D, Fang C, Li C, Wang M, Liu Y et al (2020) Perinatal transmission of COVID-19 associated SARS-CoV-2: should we worry? Clin Infect Dis. Pii: ciaa226. https://doi.org/10.1093/cid/ciaa226. [Epub ahead of print]
Liu D, Li L, Wu X, Zheng D, Wang J, Yang L et al (2020) Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. AJR Am J Roentgenol 18:1–6
Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X et al (2020) Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-Centre, descriptive study. Lancet Infect Dis 20(5):559–564
Wang X, Zhou Z, Zhang J, Zhu F, Tang Y, Shen X (2020) A case of 2019 novel coronavirus in a pregnant woman with preterm delivery. Clin Infect Dis. Pii: ciaa200. https://doi.org/10.1093/cid/ciaa200. [Epub ahead of print]
Khan S, Peng L, Siddique R, Nabi G, Xue M, Liu J et al (2020) Impact of COVID-19 infection on pregnancy outcomes and the risk of maternal-to-neonatal intrapartum transmission of COVID-19 during natural birth. Infect Control Hosp Epidemiol 19:1–3
Zambrano LI, Fuentes-Barahona IC, Bejarano-Torres DA, Bustillo C, Gonzales G, Vallecillo-Chinchilla G et al (2020) A pregnant woman with COVID-19 in Central America. Travel Med Infect Dis. 101639. https://doi.org/10.1016/j.tmaid.2020.101639. [Epub ahead of print]
Tabatabaeizadeh SA, Avan A, Bahrami A, Khodashenas E, Esmaeili H, Ferns GA et al (2017) High-dose supplementation of vitamin D affects measures of systemic inflammation: reductions in high-sensitivity C-reactive protein level and neutrophil to lymphocyte ratio (NLR) distribution. J Cell Biochem 118(12):4317–4322
Chen D, Yang H, Cao Y, Cheng W, Duan T, Fan C et al (2020) Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID-19) infection. Int J Gynaecol Obstet 149(2):130–136
Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M et al (2020) Outcome of coronavirus spectrum infections (SARS, MERS, COVID 1-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 25:100107. https://doi.org/10.1016/j.ajogmf.2020.100107
Singhal T (2020) A review of coronavirus Disease-2019 (COVID-19). Indian J Pediatr 87(4):281–286
Handbook of COVID-19 Prevention and Treatment. Chinese guidelines (2020). alnap.org/help-library/handbook-of-covid-19-prevention-and-treatment
Interim Clinical Guidance for Management of Patients, CDC guidelines (2020). www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M et al (2020) Hematological findings and complications of COVID-19. Am J Hematol. https://doi.org/10.1002/ajh.25829. [Epub ahead of print]
Violi F, Pastori D, Cangemi R, Pignatelli P, Loffredo L (2020) Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge Thromb Haemost. https://doi.org/10.1055/s-0040-1710317. [Epub ahead of print]
Vegt J, Guest PC (2018) A user-friendly app for blood coagulation disorders. Methods Mol Biol 1735:499–504
Acknowledgments
Thanks to guidance and advice from the Clinical Research Development Unit of Baqiyatallah Hospital.
Funding Source
None
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Makvandi, S. et al. (2021). The 2019 Novel Coronavirus Disease in Pregnancy: A Systematic Review. In: Guest, P.C. (eds) Clinical, Biological and Molecular Aspects of COVID-19. Advances in Experimental Medicine and Biology(), vol 1321. Springer, Cham. https://doi.org/10.1007/978-3-030-59261-5_27
Download citation
DOI: https://doi.org/10.1007/978-3-030-59261-5_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-59260-8
Online ISBN: 978-3-030-59261-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)